Methods and compositions for impairing multiplication of hiv-1

Details for Australian Patent Application No. 2001253762 (hide)

Owner Thymon L.L.C.

Inventors Goldstein, Gideon

Agent Davies Collison Cave

Pub. Number AU-B-2001253762

PCT Pub. Number WO01/82944

Priority 09561366 28.04.00 US

Filing date 20 April 2001

Wipo publication date 12 November 2001

Acceptance publication date 22 September 2005

International Classifications

A61K 038/00 Medicinal preparations containing peptides

C07K 007/00 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 005/00 Peptides having up to four amino acids in a fully defined sequence

C07K 017/00 Carrier-bound or immobilised peptides

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 039/21 Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 039/12 Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 039/00 Medicinal preparations containing antigens or antibodies

A61K 038/04 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

Event Publications

22 September 2005 Application Accepted

  Published as AU-B-2001253762

19 January 2006 Standard Patent Sealed

21 September 2006 Licence Registered

  Thymon L.L.C. ( BioInvent International AB )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253763

2001253761